Xu-dong Tang

发表

Dendritic Cells Reconstituted with a Human Heparanase Gene Induce Potent Cytotoxic T-Cell Responses against Gastric Tumor Cells in vitro

Songtao Yu, D. Fang, Shi-ming Yang, 2007, Tumor Biology.

In vitro and in vivo evaluation of DC‑targeting PLGA nanoparticles encapsulating heparanase CD4 + and CD8 + T‑cell epitopes for cancer immunotherapy

Chen, Xu-dong Tang, Kui-Lin Lü, 2022 .

Antitumor effect of new multiple antigen peptide based on HLA‐A0201‐restricted CTL epitopes of human telomerase reverse transcriptase (hTERT)

Shiming Yang, D. Fang, Hong Guo, 2012, Cancer science.

Multiple Antigenic Peptides of Human Heparanase Elicit a Much More Potent Immune Response against Tumors

D. Fang, Ning Li, Guang-ping Liang, 2011, Cancer Prevention Research.

Cytotoxic T lymphocyte epitopes from human heparanase can elicit a potent anti-tumor immune response in mice

Songtao Yu, Y. Wan, D. Fang, 2010, Cancer Immunology, Immunotherapy.

HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy.

Songtao Yu, D. Fang, Guang-ping Liang, 2008, Neoplasia.

In vitro and ex vivo evaluation of a multi-epitope heparinase vaccine for various malignancies

Shu Guo, D. Fang, Ning Li, 2013, Cancer science.

Induction of anti‐tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice

Songtao Yu, D. Fang, Guang-ping Liang, 2009, The Journal of pathology.

Diepitope multiple antigen peptide of hTERT trigger stronger anti-tumor immune responses in vitro.

Gang Luo, Shiming Yang, Hong Guo, 2013, International immunopharmacology.

Inhibition of tankyrase 1 in human gastric cancer cells enhances telomere shortening by telomerase inhibitors.

H. Zhang, Songtao Yu, D. Fang, 2010, Oncology reports.

Multiple Antigenic Peptides Based on H-2Kb–Restricted CTL Epitopes from Murine Heparanase Induce a Potent Antitumor Immune Response In Vivo

Jun-Gu Guo, D. Fang, Ning Li, 2012, Molecular Cancer Therapeutics.

Preclinical Development Multiple Antigenic Peptides Based on H-2 Kb – Restricted CTL Epitopes fromMurineHeparanase Induce aPotent Antitumor Immune Response In Vivo

Jun-Gu Guo, D. Fang, Ning Li, 2012 .

Noninvasive and real‐time monitoring of the therapeutic response of tumors in vivo with an optimized hTERT promoter

Songtao Yu, D. Fang, Ning Li, 2012, Cancer.

H-2Kb-restricted CTL epitopes from mouse heparanase elicit an antitumor immune response in vivo.

Songtao Yu, D. Fang, Guang-ping Liang, 2008, Cancer research.

An optimized telomerase-specific lentivirus for optical imaging of tumors.

Songtao Yu, D. Fang, Guang-ping Liang, 2010, Cancer research.

hTERT promotes the invasion of telomerase-negative tumor cells in vitro.

Songtao Yu, D. Fang, Shi-ming Yang, 2009, International journal of oncology.

Heparanase: a universal immunotherapeutic target in human cancers.

Yafei Zhang, D. Fang, Shi-ming Yang, 2011, Drug discovery today.

In vitro and in vivo evaluation of DC-targeting PLGA nanoparticles encapsulating heparanase CD4+ and CD8+ T-cell epitopes for cancer immunotherapy

Kui-lin Lü, Xu-dong Tang, Hanjian Du, 2022, Cancer Immunology, Immunotherapy.

In vitro and in vivo evaluation of DC-targeting PLGA nanoparticles encapsulating heparanase CD4+ and CD8+ T-cell epitopes for cancer immunotherapy

Kui-lin Lü, Xu-dong Tang, Hanjian Du, 2022, Cancer Immunology and Immunotherapy.

In vitro anti-tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus.

Songtao Yu, D. Fang, Guang-ping Liang, 2006, Biochemical and biophysical research communications.

Multiple Antigenic Peptides Based on H-2Kb–Restricted CTL Epitopes from Murine Heparanase Induce a Potent Antitumor Immune Response In Vivo

Jun-Gu Guo, D. Fang, Ning Li, 2012, Molecular Cancer Therapeutics.